Courtney Coker

6PUBLICATIONS

36CO-AUTHORS

Medical bacteriologyMolecular targetsPredictive and prognostic markersBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Nov 06, 2026

Engineered probiotics target granulomas to treat mycobacterial infection.

|Jul 02, 2024

FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.

Yifan Tai, Angela Chow, Seoyoung Han

|Jan 20, 2024

Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia.

Candice R Gurbatri, Georgette A Radford, Laura Vrbanac

|Oct 12, 2023

Probiotic-guided CAR-T cells for solid tumor targeting.

Rosa L Vincent, Candice R Gurbatri, Fangda Li

|Mar 08, 2023

Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity.

Thomas M Savage, Rosa L Vincent, Sarah S Rae

|Oct 14, 2022

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.

Paul K Paik, Jia Luo, Ni Ai

Pageof 1

Frequent Collaborators

Tal Danino

Jongwon Im

Nicholas Arpaia

Thomas Savage

Rosa L Vincent

Kenia de Los Santos-Alexis

Paul K Paik

Jia Luo

Phillip Wong

Sarah S Rae

Frequent Collaborators

Tal Danino

Jongwon Im

Nicholas Arpaia

Thomas Savage